FDA Clears First Single-Biomarker Blood Test for Alzheimer’s Disease
FDA Clears First Single-Biomarker Blood Test for Alzheimer’s Disease The US Food and Drug Administration (FDA) has cleared the Elecsys Phospho-Tau (217P) Plasma test —...
32 articles
FDA Clears First Single-Biomarker Blood Test for Alzheimer’s Disease The US Food and Drug Administration (FDA) has cleared the Elecsys Phospho-Tau (217P) Plasma test —...
A landmark study published in Neurology, the medical journal of the American Academy of Neurology, has found that women who used estrogen-only menopausal hormone therapy...
WHO Issues New Recommendations for Reducing Cognitive Decline The World Health Organization (WHO) has released updated guidelines on reducing the risk of cognitive decline and...
WHO Unveils Updated Guidelines to Combat Rising Dementia Rates Worldwide The World Health Organization (WHO) has officially launched the second edition of its Guidelines on...
Scientists reverse Alzheimer's in mice using breakthrough nanoparticles that cross the blood-brain barrier. Could this lead to a human cure for dementia?
William Dale, director of the Center for Cancer and Aging and vice chair for academic affairs in the Department of Supportive Care Medicine at City of H...
Rakesh Amin, MD, discusses the toll that schizophrenia takes on caregivers, how caregivers of schizophrenia patients can best support themselves, as wel...
Andrea Bozoki, Division Chief and Professor of Memory and Cognitive Disorders at the University of North Carolina at Chapel Hill, and Susan Dickinson, C...
Primo Castro, American Cancer Society - Cancer Action Network (ACS CAN) advocate, speaks out to share his story and what his home state is doing throu...
Trish Richardson, MSN, BSBA, RN, NE-BC, CMSRN, Director of Post-Acute Care Solutions at Relias, a healthcare training and performance solutions company,...